Back to User profile » Dr Yeon-Tae Chung
Paper published by Dr Yeon-Tae Chung:
Original Research
A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson’s disease, in healthy volunteers
Shin W, Lim KS, Kim MK, Kim HS, Hong J, Jhee S, Kim J, Yoo S, Chung YT, Lee JM, Cho DY
Drug Design, Development and Therapy 2019, 13:1011-1022
Published Date: 29 March 2019